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Background: Isoprenoids constitute a vast family of natural compounds performing diverse and essential functions
in all domains of life. In most eubacteria, isoprenoids are synthesized through the methylerythritol 4-phosphate
(MEP) pathway. The production of MEP is usually catalyzed by deoxyxylulose 5-phosphate reductoisomerase (DXR-I)
but a few organisms use an alternative DXR-like enzyme (DXR-II).
Results: Searches through 1498 bacterial complete proteomes detected 130 sequences with similarity to DXR-II.
Phylogenetic analysis identified three well-resolved clades: the DXR-II family (clustering 53 sequences including
eleven experimentally verified as functional enzymes able to produce MEP), and two previously uncharacterized
NAD(P)-dependent oxidoreductase families (designated DLO1 and DLO2 for DXR-II-like oxidoreductases 1 and 2).
Our analyses identified amino acid changes critical for the acquisition of DXR-II biochemical function through type-I
functional divergence, two of them mapping onto key residues for DXR-II activity. DXR-II showed a markedly
discontinuous distribution, which was verified at several levels: taxonomic (being predominantly found in
Alphaproteobacteria and Firmicutes), metabolic (being mostly found in bacteria with complete functional MEP
pathways with or without DXR-I), and phenotypic (as no biological/phenotypic property was found to be
preferentially distributed among DXR-II-containing strains, apart from pathogenicity in animals). By performing a
thorough comparative sequence analysis of GC content, 3:1 dinucleotide frequencies, codon usage and codon
adaptation indexes (CAI) between DXR-II sequences and their corresponding genomes, we examined the role of
horizontal gene transfer (HGT), as opposed to an scenario of massive gene loss, in the evolutionary origin and
diversification of the DXR-II subfamily in bacteria.
Conclusions: Our analyses support a single origin of the DXR-II family through functional divergence, in which
constitutes an exceptional model of acquisition and maintenance of redundant gene functions between non-
homologous genes as a result of convergent evolution. Subsequently, although old episodic events of HGT could
not be excluded, the results supported a prevalent role of gene loss in explaining the distribution of DXR-II in
specific pathogenic eubacteria. Our results highlight the importance of the functional characterization of
evolutionary shortcuts in isoprenoid biosynthesis for screening specific antibacterial drugs and for regulating the
production of isoprenoids of human interest.
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Isoprenoids constitute the largest family of natural com-
pounds both at a structural and functional level [1-3].
They are found in all the three domains of life (bacteria,
archaea, and eukaryotes). Despite their diversity in struc-
tures and functions, all isoprenoids derive from the com-
mon five-carbon precursors isopentenyl diphosphate (IPP)
and its isomer dimethylallyl diphosphate (DMAPP). IPP
can be synthesized through two independent metabolic
pathways, the mevalonate (MVA) pathway, or the more
recently elucidated methylerythritol 4-phosphate (MEP)
pathway [4] (Figure 1). In most eubacteria, isoprenoids are
synthesized through the MEP pathway, while a few species
use the MVA pathway, both pathways, or none, the latter
obtaining their isoprenoids from host cells [5-8]. Previous
analysis suggested that eukaryotes have inherited MEP
and MVA pathways genes from eubacteria and archaebac-
teria, respectively, as reflected by their phylogenetic distri-
bution [5]. In plants, plastidial IPP and DMAPP are
synthesized through the MEP pathway, whereas cytosolic
and mitochondrial isoprenoids are synthesized through
the MVA pathway [4,9]. Non-photosynthetic simpler
plastid-bearing organisms, such as the apicomplexan pro-
tists, solely use the MEP pathway [10]. In contrast, in yeast
and animals, all isoprenoids are synthesized through theHMGR
IDI 
acetoacetyl-CoA 
HMG-CoA 
MVA 
MVP 
MVPP 
AACT 
HMGS 
PMK 
MVK 
PMD 
acetyl-CoA 
DXP 
CDP-ME 
CDP-MEP 
MEcPP 
HMBPP 
IPPDMAPP
 Pyruvate GAP +   
DXS 
DXR-I/DXR-II
MCT
MDS 
CMK 
HDS 
IDI 
MEP 
HDR
IPP
O
OH
OH
P
O
O
O
O
O
OH
OH
P
O
O
O
OH
A 
Figure 1 Isoprenoid and amino acid biosynthetic pathways. A) Pathwa
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steps and dashed arrows mark multiple steps.MVA pathway [11]. The lack of MEP pathway enzymes in
non-plastid bearing eukaryotes suggests that these genes
were acquired through gene transfer to the nucleus from
the eubacterial endosymbiotic ancestors that gave rise to
plastids [5,12].
Isoprenoids are essential in all eubacteria in which
they have been studied, playing key roles in several core
cellular functions e.g. ubiquinones and menaquinones,
which act as electron carriers of the aerobic and anaer-
obic respiratory chains respectively, and dolichols, which
are required for cell wall peptidoglycan synthesis [13].
Because of the essential role of the MEP pathway in
most eubacteria and its absence from animals, it has
been proposed as a promising new target for the devel-
opment of novel antibiotics [14,15]. Besides that, many
isoprenoids also have substantial industrial, pharma-
cological, and nutritional interest [16]. Therefore, un-
derstanding the biochemical and genetic plasticity of
isoprenoid biosynthesis in bacteria is crucial to attempt
its pharmacological block or to be used in biofactories
for the production of isoprenoids of human interest.
The occurrence of alternative enzymes for isoprenoid
biosynthesis in specific bacterial lineages has been previ-
ously reported [17]. The enzyme 3-hydroxy-3-methyl-
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distant from its archaebacterial and eukaryotic homologs
in most eubacteria [8,18,19]. Similarly, two different
classes of isopentenyl diphosphate isomerase (IDI), the
enzyme catalyzing the isomerization of IPP to produce
DMAPP, have been identified in bacteria: type I IDI
(similar to its animal, fungi and plant counterparts) and
type II IDI, acquired from archaebacteria and apparently
unrelated to the latter [20-22]. Although IDI activity is
only essential in organisms dependent on the MVA
pathway for IPP and isoprenoid biosynthesis, both types
of IDI have been identified in bacterial strains dependent
on the MEP pathway [7].
We recently reported the occurrence of a group of
bacteria harbouring the entire set of enzymes of the
MEP pathway with the exception of 1-deoxy-d-xylulose
5-phosphate (DXP) reductoisomerase (DXR), the en-
zyme catalyzing the NADPH-dependent production of
MEP from DXP in the first committed step of the path-
way. In these species, a novel family of previously
uncharacterized oxidoreductases related to homoserine
dehydrogenases (HD) involved in the common pathway
(CP) of amino acid biosynthesis (Figure 1), was found to
perform the DXR biochemical reaction [23]. This alter-
native enzyme, referred to as DXR-like (DRL) or DXR
type II (DXR-II) to distinguish it from the canonical
DXR (renamed DXR-I), displayed a markedly discontinu-
ous distribution. DXR-II was found forming single or
multigene families in bacterial strains from diverse taxo-
nomic groups, independent of the presence or absence
of a DXR-I sequence in their genome [23].
Different evolutionary scenarios might explain DXR-II
emergence and evolutionary diversification. In this study
we examined how the DXR-II family emerged through
functional divergence from related oxidoreductase fam-
ilies and identified amino acid changes critical for the
acquisition of its specific biochemical function. Further-
more, we assess the contrasting roles of horizontal gene
transfer (HGT) and massive gene loss, major forces in
microbial genome evolution known to affect other genes
involved in IPP and isoprenoid biosynthesis [24], in the
discontinuous distribution of DXR-II across eubacteria.
Results
DXR-IIs cluster into a single clade closely related to two
uncharacterized oxidoreductase families
The complete proteomes of 1489 eubacterial strains
were screened for the occurrence of DXR-II sequences
using the protein sequence from Brucella melitensis
biovar abortus 2308 DXR-II (formerly Brucella abortus
2308, gene id: 83269188) as a query [23]. To reduce false
positives caused by hits corresponding to distantly
related sequences, we applied a best reciprocal hitcriterion i.e. orthology was assumed only if two genes in
each different genome are each other’s best hit [25]. In-
deed, eight sequences were not confirmed as reciprocal
best hits, including two identified in a previous survey
conducted following a unidirectional BLAST search ap-
proach [23], and these were consequently discarded
from further analyses. 128 sequence hits were identified
in as many bacterial strains (Table 1), belonging to a wide
variety of the main bacterial taxonomic groups (Figure 2).
Among these, two bacterial strains (Mesorhizobium loti
MAFF303099 and Ochrobactrum anthropi ATCC 49188)
had been previously shown to code for additional func-
tional DXR-II paralogs [23] that were not identified by our
analysis, specifically designed to identify co-orthologs in
genome wide scans, but were added to the final dataset
(Table 1).
Using the amino acid sequence alignment of the
resulting full dataset of 130 hits (Additional file 1), a
maximum likelihood (ML) phylogenetic analysis was
performed (Figure 2 and Additional file 2). Alternative
methods of phylogenetic inference (Bayesian -Additional
file 3- and neighbor joining -Additional file 4) were also
implemented, resulting in trees with almost identical
topologies (unpublished data). Three main clades were
consistently retrieved with high support values (Figure 2).
A clade grouping 53 sequences, including 11 encoding
for functional DXR-II as shown in complementation as-
says in [23] and Additional file 5, was designated as the
DXR-II family and likely corresponds to actual DXR-II
sequences (Figure 2). The remaining 77 sequences cluster
into two additional clades and might not be true func-
tional DXR-II sequences (Figure 2). As such, these were
tentatively designated DLO1 and DLO2, for DXR-II-Like
1 and 2 Oxidoreductases. Indeed, four representative se-
quences belonging to the DLO1 and 2 families had also
been previously tested for DXR-II activity, failing to com-
plement the DXR defective mutant (Figure 2) [23].
DXR-II and DLO sequences showed similarity to NAD
(P)-dependent oxidoreductases, and particularly to HD
enzymes, at a sequence [23] and structural level [26].
Correspondingly, searches for INTERPRO functional do-
mains identified the NAD-binding domain with a core
Rossmann-type fold at the N-terminal region of every
single protein sequence (domain 1; Figure 2). Up to five
additional domains could also be found in DXR-II and
DLO proteins. To examine whether these protein domains
were differentially distributed across the DXR-II, DLO1,
and DLO2 families, we mapped the architecture of protein
domains onto the corresponding tree (Figure 2). Most se-
quences from the DXR-II family shared NAD-binding
(domain 1) and SAF (domain 6) domains, while a signifi-
cant fraction also included N-terminal NAD/NADP-bind-
ing domains of aspartate/homoserine dehydrogenase
(domain 2). However, no common domain architecture
Table 1 List of DXR-II and DLO related sequences examined in this study
Bacterial strain UID GenBank and RefSeq Bacterial strain UID GenBank and RefSeq
DXR-II Anaerococcus prevotii
DSM 20548
59219 gi|257066990|ref|YP_003153246.1 DLO1 Frankia sp. EuI1c 42615 gi|312199021|ref|YP_004019082.1
Bacillus clausii KSM-K16 58237 gi|56965002|ref|YP_176733.1 Gloeobacter violaceus
PCC 7421
58011 gi|37521773|ref|NP_925150.1
Bacillus halodurans
C-125
57791 gi|15613337|ref|NP_241640.1 Hirschia baltica
ATCC 49814
59365 gi|254294497|ref|YP_003060520.1
Bacillus pumilus
SAFR-032
59017 gi|157692210|ref|YP_001486672.1 Kineococcus
radiotolerans SRS30216
58067 gi|152964541|ref|YP_001360325.1
Bartonella bacilliformis
KC583
58533 gi|121601844|ref|YP_989368.1 Methanosphaerula
palustris E1-9c
59193 gi|219852978|ref|YP_002467410.1
Bartonella clarridgeiae
73
62131 gi|319898668|ref|YP_004158761.1 Nakamurella
multipartita DSM 44233
59221 gi|258653356|ref|YP_003202512.1
Bartonella grahamii
as4aup
59405 gi|240851045|ref|YP_002972445.1 Nostoc azollae 0708 49725 gi|298491811|ref|YP_003721988.1
Bartonella henselae
str. Houston-1
57745 gi|49475991|ref|YP_034032.1 Nostoc punctiforme
PCC 73102
57767 gi|186681545|ref|YP_001864741.1
Bartonella quintana
str. Toulouse
57635 gi|49474558|ref|YP_032600.1 Nostoc sp. PCC 7120 57803 gi|17230323|ref|NP_486871.1
Bartonella tribocorum
CIP 105476
59129 gi|163868831|ref|YP_001610057.1 Pseudomonas stutzeri
A1501
58641 gi|146282531|ref|YP_001172684.1
Brucella abortus
bv. 1 str. 9-941
58019 gi|62317206|ref|YP_223059.1 Pseudomonas stutzeri
ATCC 17588 = LMG 11199
68749 gi|339494143|ref|YP_004714436.1
Brucella abortus S19 58873 gi|189022468|ref|YP_001932209.1 Pseudoxanthomonas
spadix BD-a59
75113 gi|357416048|ref|YP_004929068.1
Brucella canis ATCC
23365
59009 gi|161621022|ref|YP_001594908.1 Ramlibacter
tataouinensis TTB310
68279 gi|337280130|ref|YP_004619602.1
Brucella melitensis ATCC
23457
59241 gi|225686729|ref|YP_002734701.1 Rhodobacter
sphaeroides 2.4.1
57653 gi|77463590|ref|YP_353094.1
Brucella melitensis
biovar Abortus 2308
62937 gi|83269188|ref|YP_418479.1 Rhodobacter
sphaeroides ATCC 17025
58451 gi|146278215|ref|YP_001168374.1
Brucella melitensis
bv. 1 str. 16 M
57735 gi|17988671|ref|NP_541304.1 Rhodobacter
sphaeroides ATCC 17029
58449 gi|126462422|ref|YP_001043536.1
Brucella microti CCM
4915
59319 gi|256015731|ref|YP_003105740.1 Rhodobacter
sphaeroides KD131
59277 gi|221639432|ref|YP_002525694.1
Brucella ovis
ATCC 25840
58113 gi|148558391|ref|YP_001257886.1 Rhodothermus marinus
DSM 4252
41729 gi|268316714|ref|YP_003290433.1
Brucella pinnipedialis
B2/94
71131 gi|340792737|ref|YP_004758201.1 Rhodothermus marinus
SG0.5JP17-172
72767 gi|345303494|ref|YP_004825396.1
Brucella suis 1330 57927 gi|23500696|ref|NP_700136.1 Sphingomonas
wittichii RW1
58691 gi|148557435|ref|YP_001265017.1
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Table 1 List of DXR-II and DLO related sequences examined in this study (Continued)
Brucella suis ATCC
23445
59015 gi|163845083|ref|YP_001622738.1 Streptomyces griseus
subsp. griseus NBRC
13350
58983 gi|182439707|ref|YP_001827426.1
Chelativorans sp. BNC1 58069 gi|110636013|ref|YP_676221.1 Xanthomonas
campestris pv.
campestris str. 8004
57595 gi|77761197|ref|YP_243248.2
Chloroflexus
aurantiacus J-10-fl
57657 gi|163846900|ref|YP_001634944.1 Xanthomonas
campestris pv.
campestris str. ATCC
33913
57887 gi|77747863|ref|NP_637377.2
Chloroflexus sp. Y-400-fl 59085 gi|222524722|ref|YP_002569193.1 Xanthomonas
campestris pv.
campestris str. B100
61643 gi|188991706|ref|YP_001903716.1
Clostridium difficile 630 57679 gi|126700028|ref|YP_001088925.1 DLO2 Achromobacter
xylosoxidans A8
59899 gi|311109080|ref|YP_003981933.1
Clostridium difficile
CD196
41017 gi|260683992|ref|YP_003215277.1 Acidiphilium cryptum
JF-5
58447 gi|148260557|ref|YP_001234684.1
Clostridium difficile
R20291
40921 gi|260687652|ref|YP_003218786.1 Acidiphilium
multivorum
63345 gi|326403752|ref|YP_004283834.1
Eubacterium limosum
KIST612
59777 gi|310828050|ref|YP_003960407.1 Acidovorax ebreus TPSY 59233 gi|222110742|ref|YP_002553006.1
Finegoldia magna ATCC
29328
58867 gi|169824217|ref|YP_001691828.1 Acidovorax sp. JS42 58427 gi|121594656|ref|YP_986552.1
Halanaerobium
hydrogeniformans
60191 gi|312144614|ref|YP_003996060.1 Actinosynnema mirum
DSM 43827
58951 gi|256377798|ref|YP_003101458.1
Listeria innocua
Clip11262
61567 gi|16799625|ref|NP_469893.1 Agrobacterium
sp. H13-3
63403 gi|332715931|ref|YP_004443397.1
Listeria ivanovii 73473 gi|347547952|ref|YP_004854280.1 Agrobacterium
tumefaciens str. C58
57865 gi|15891768|ref|NP_357440.1
Listeria monocytogenes 43671 gi|284800826|ref|YP_003412691.1 Anaeromyxobacter
sp. Fw109-5
58755 gi|153005951|ref|YP_001380276.1
Listeria monocytogenes
08-5923
43727 gi|284994012|ref|YP_003415780.1 Arthrobacter sp. FB24 58141 gi|116672147|ref|YP_833080.1
Listeria monocytogenes
EGD-e
61583 gi|16802589|ref|NP_464074.1 Azorhizobium
caulinodans ORS 571
58905 gi|158423518|ref|YP_001524810.1
Listeria monocytogenes
HCC23
59203 gi|217965360|ref|YP_002351038.1 Bordetella avium 197 N 61563 gi|187476836|ref|YP_784860.1
Listeria monocytogenes
serotype 4b str. CLIP
80459
59317 gi|226223175|ref|YP_002757282.1 Bordetella
bronchiseptica RB50
57613 gi|33599421|ref|NP_886981.1
Listeria monocytogenes
serotype 4b str. F2365
57689 gi|46906791|ref|YP_013180.1 Bordetella parapertussis
12822
57615 gi|33595139|ref|NP_882782.1
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Table 1 List of DXR-II and DLO related sequences examined in this study (Continued)
Listeria welshimeri
serovar 6b str. SLCC5334
61605 gi|116871936|ref|YP_848717.1 Bordetella petrii DSM
12804
61631 gi|163858833|ref|YP_001633131.1
Mesorhizobium ciceri
biovar biserrulae
WSM1271
62101 gi|319781195|ref|YP_004140671.1 Bradyrhizobium
japonicum USDA 110
57599 gi|27382926|ref|NP_774455.1
Mesorhizobium loti
MAFF303099 (1)
57601 gi|13473132|ref|NP_104699.1 Bradyrhizobium
sp. BTAi1
58505 gi|148252763|ref|YP_001237348.1
Mesorhizobium loti
MAFF303099 (2)
57601 gi|13475431|ref|NP_106995.1 Bradyrhizobium
sp. ORS278
58941 gi|146343223|ref|YP_001208271.1
Mesorhizobium
opportunistum
WSM2075
40861 gi|337266026|ref|YP_004610081.1 Candidatus Pelagibacter
ubique HTCC1062
58401 gi|71083552|ref|YP_266271.1
Ochrobactrum anthropi
ATCC 49188 (1)
58921 gi|153008718|ref|YP_001369933.1 Cupriavidus necator N-1 68689 gi|339328796|ref|YP_004688488.1
Ochrobactrum anthropi
ATCC 49188 (2)
58921 gi|153011435|ref|YP_001372649.1 Cupriavidus taiwanensis 61615 gi|194292943|ref|YP_002008850.1
Pelagibacterium
halotolerans B2
74393 gi|357386128|ref|YP_004900852.1 Methylibium
petroleiphilum PM1
58085 gi|124268433|ref|YP_001022437.1
Roseobacter litoralis
Och 149
54719 gi|339504759|ref|YP_004692179.1 Methylobacterium
nodulans ORS 2060
59023 gi|220926646|ref|YP_002501948.1
Sebaldella termitidis
ATCC 33386
41865 gi|269122365|ref|YP_003310542.1 Methylobacterium
radiotolerans JCM 2831
58845 gi|170751253|ref|YP_001757513.1
Sinorhizobium fredii
NGR234
59081 gi|227820170|ref|YP_002824141.1 Methylobacterium
sp. 4-46
58843 gi|170738904|ref|YP_001767559.1
Starkeya novella DSM
506
48815 gi|298294348|ref|YP_003696287.1 Mycobacterium
smegmatis str. MC2 155
57701 gi|118472915|ref|YP_885297.1
Tepidanaerobacter
sp. Re1
66873 gi|332798945|ref|YP_004460444.1 Nocardiopsis
dassonvillei subsp.
dassonvillei DSM 43111
49483 gi|297561288|ref|YP_003680262.1
Thermosediminibacter
oceani DSM 16646
51421 gi|302389988|ref|YP_003825809.1 Paracoccus denitrificans
PD1222
58187 gi|119386102|ref|YP_917157.1
Verminephrobacter
eiseniae EF01-2
58675 gi|121609190|ref|YP_996997.1 Polaromonas sp. JS666 58207 gi|91787595|ref|YP_548547.1
DLO1 Anabaena variabilis
ATCC 29413
58043 gi|75907337|ref|YP_321633.1 Polymorphum gilvum
SL003B-26A1
65447 gi|328544682|ref|YP_004304791.1
Chloroflexus aggregans
DSM 9485
58621 gi|219849032|ref|YP_002463465.1 Polynucleobacter
necessarius subsp.
asymbioticus QLW-
P1DMWA-1
58611 gi|145589731|ref|YP_001156328.1
Coraliomargarita
akajimensis DSM 45221
47079 gi|294053940|ref|YP_003547598.1 Pusillimonas sp. T7-7 66391 gi|332284324|ref|YP_004416235.1
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Table 1 List of DXR-II and DLO related sequences examined in this study (Continued)
Coxiella burnetii
CbuG_Q212
58893 gi|212211864|ref|YP_002302800.1 Rhodopseudomonas
palustris BisB5
58441 gi|91978550|ref|YP_571209.1
Coxiella burnetii
CbuK_Q154
58895 gi|212217809|ref|YP_002304596.1 Rhodospirillum rubrum
ATCC 11170
57655 gi|83594471|ref|YP_428223.1
Coxiella burnetii
Dugway 5 J108-111
58629 gi|154707185|ref|YP_001423500.1 Spirochaeta
smaragdinae
DSM 11293
51369 gi|302337774|ref|YP_003802980.1
Coxiella burnetii
RSA 331
58637 gi|161830312|ref|YP_001597660.1 Spirochaeta sp. Buddy 63633 gi|325972507|ref|YP_004248698.1
Coxiella burnetii
RSA 493
57631 gi|29655123|ref|NP_820815.1 Streptomyces
flavogriseus ATCC 33331
40839 gi|357414986|ref|YP_004926722.1
Cyanothece sp.
PCC 7425
59435 gi|220910534|ref|YP_002485845.1 Streptomyces sp.
SirexAAcpoE
72627 gi|345003166|ref|YP_004806020.1
Cyclobacterium
marinum DSM 745
71485 gi|343084038|ref|YP_004773333.1 Variovorax paradoxus
EPS
62107 gi|319794630|ref|YP_004156270.1
Deinococcus
maricopensis
DSM 21211
62225 gi|320332781|ref|YP_004169492.1 Variovorax paradoxus
S110
59437 gi|239816446|ref|YP_002945356.1
Desulfococcus
oleovorans Hxd3
58777 gi|158521221|ref|YP_001529091.1 Xanthobacter
autotrophicus Py2
58453 gi|154244830|ref|YP_001415788.1
UID (taxonomy) Unique IDentifier.
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Figure 2 Phylogeny of DXR-II and DLO related sequences. ML cladogram depicting the evolutionary relationships among 53 DXR-II and 77
related protein sequences. Three clades defining main families are indicated. Statistical support on relevant clades is indicated by values next to
nodes (ML aLRT support values/BA posterior probabilities/NJ bootstrap values). Sequence names are colored according to taxonomical groups
(see legend). Sequence names include the bacterial strain name, followed by two pairs of square brackets: the first pair encloses the classification
of the given bacterial strain according to the distribution of enzymes of the i) MEP and MVA pathways, left side of the vertical bar (i.e. classes A, +MEP
pathway enzymes –DXR; B, +MEP pathway enzymes + DXR; C, -MEP +MVA pathway enzymes -DXR; D, +MEP +MVA pathway enzymes + DXR; E, -MEP
-MVA pathway enzymes -DXR) and ii) CP pathway, right side of the vertical bar (i.e. A, complete CP pathway; B, incomplete CP pathway –AK_HD). The
second pair of brackets represents the INTERPRO protein functional domains found i.e. 1, NAD(P)-binding domain (IPR016040); 2, Aspartate/
homoserine dehydrogenase, NAD-binding (IPR005106); 3, Oxidoreductase, N-terminal (IPR000683); 4, Dihydrodipicolinate reductase, N-terminal
(IPR000846); 5, Quinate/shikimate 5-dehydrogenase/glutamyl-tRNA reductase (IPR006151); 6, SAF domain (IPR013974). Asterisks indicate
sequences for which DXR-II activity was previously tested through complementation assays [23] and Additional file 5.
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DLO2.
The DXR-II family emerged through functional divergence
Phylogenetic analysis revealed the shared ancestry of all
functional DXR-II, supporting their common evolutionaryorigin, and suggested the functional divergence of this
family from related oxidoreductases through the ac-
quisition of DXR-II specific biochemical activity. To
examine the role of specific amino acid substitutions in
functional specialization of DXR-II protein sequences, two
different statistical approaches under a ML framework
were followed. The first one permits the detection of
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between families under examination, i.e., highly conserved
in a family but variable in the other (type-I functional di-
vergence) [27]. The second approach relies on site-specific
shifts of amino acid physiochemical properties in positions
otherwise highly conserved in each family (type-II func-
tional divergence) [28].
Given the ML tree topology (Figure 2), the ML esti-
mates of the theta (θ) coefficients for type-I functional di-
vergence between the DXR-II family and families DLO1
and DLO2 were statistically significant in both cases
(Table 2). This implies that structural and/or functional
selective constraints at some sites have shifted significantly
after the divergence of DXR-II from both DLO families. In
contrast, the corresponding tests did not support type-II
functional divergence (Table 2). Moreover, 28 and 34 spe-
cific amino acid residues, including 8 and 11 with high
posterior probabilities, were predicted as responsible for
type-I functional divergence of DXR-II from DLO families
1 and 2, respectively (Table 2). Interestingly, seven sites
detected as key for functional divergence were shared in
analyses between the DXR-II family and both the DLO1
and DLO2 families.
These sites were mapped onto the corresponding
amino acid sequence alignment (Additional file 1 and
Additional file 6: Table S1). At many of these sites,
amino acid residues are highly conserved in DXR-II se-
quences, but are variable in the DLO1 (e.g. positions 161
and 429 in B. melitensis biovar abortus 2308 DXR-II),
the DLO2 (e.g. positions 210, 248 and 324), or both the
DLO1 and the DLO2 (e.g. positions 35, 64, 118, 121,
122, 133, 197, 229, 250, 291, 320, 330, 346, 351, 353,
413, 428, 429, 432) families, likely reflecting a change in
their functional roles. Some apparently represented
minor changes, as they involved amino acids with simi-
lar physicochemical features (e.g. positions 291 or 428).
Some others involved radical amino acid changes, such
as position 121, occupied by the highly conserved Gly in
DXR-II proteins, but also by the unrelated Ala and Ser
amino acids in DLO1 and DLO2 proteins. Another ex-
ample is position 229, filled by the absolutely conserved
polar amino acid Thr in DXR-II proteins, but replaced
by the highly hydrophobic Leu, Ile and Val amino acids
in DLO1 or the physicochemically unrelated Pro, Ser
and Ala residues in DLO2. Likewise, position 250, with
a basic polar His found in all but four DXR-II proteins
was replaced by different hydrophobic amino acids,
and finally position 351, with a conserved Val in most
DXR-II proteins was substituted by different physico-
chemically unrelated amino acids in DLO1 and DLO2
proteins.
To gain further insights into their putative functional
impact, the amino acid changes detected as related to
functional divergence of DXR-II were mapped onto thethree-dimensional structure of B. melitensis biovar abor-
tus 2308 DXR-II in its apo form and in complex with
the competitive inhibitor fosmidomycin (Figure 3) [26].
Predicted sites were mostly distributed through the mid-
dle catalytic domain, but some were also found in the
COOH-terminal and NH2-terminal NADP-binding do-
mains (Figure 3A). Two predicted sites corresponded to
the conserved residues 229 and 320, identified as im-
portant for DXR-II activity [26]. Thr229, together with
Lys191 and Lys193, serve to anchor fosmidomycin, pre-
sumably participating in the proper binding of the sub-
strate (Figure 3B). Arg320 is located in a cavity at the
dimer interface and, together with positions Glu174,
Phe178 and Tyr322, may be involved in interactions be-
tween the two subunits of the DXR-II dimer (Figure 3C).
DXR-IIs show a discontinuous taxonomic, metabolic and
phenotypic distribution among eubacteria
The markedly scattered distribution of sequences be-
longing to the DXR-II family across higher order eubac-
terial taxonomic groups was previously observed [23]. In
this up-to-date survey, DXR-IIs were found as encoded
by the genomes of free-living eubacteria strains mostly
from Alphaproteobacteria (26 strains, mainly from the
genera Brucella, 11, and Bartonella, 6) and Firmicutes
(21 strains, mainly from the genus Listeria, 9). However,
genes coding for functional DXR-II representatives were
also found in the genomes of three additional distantly
related bacterial taxonomic lineages i.e. the Chloroflexi,
Betaproteobacteria and Fusobacteria (Figure 2). Within
the DXR-II family, Alphaproteobacteria, Firmicutes and
Chloroflexi sequences clustered into separate subclades,
while the single Betaproteobacteria and Fusobacteria
representatives grouped within the Alphaproteobacteria
and Firmicutes subclades, respectively (Figure 2).
We examined the distribution of functional DXR-II at
lower taxonomical levels. For example, the occurrence
of discontinuities was evident when we mapped DXR-II
onto a tree depicting the evolutionary relationships of 72
alphaproteobacterial species (Additional file 7) [30].
DXR-II genes could only be found in the genomes of 25
strains among the 64 with fully sequenced genomes rep-
resented in the tree. They mainly belong to the order
Rhizobiales, although significant hits were also retrieved
from other taxonomic ranks, such as Rhodospirillales or
Rhodobacteraceae. Within these alphaproteobacterial
groups, strains whose genomes contained genes both en-
coding and not encoding DXR-II and/or DXR-I could be
found. Discontinuities in DXR-II distribution could be
appreciated with, e.g., the closely related pairs of
Rhodospirillales species Magnetospirillum magneticum
AMB-1/Rhodospirillum rubrum ATCC 11170 and
Acidiphilium cryptum JF-5/Gluconobacter oxydans
621H. More strikingly, we have retrieved a DXR-II
Table 2 Analysis of functional divergence
Functional
divergence
Families Coefficient θ ± SE Critical amino acid sites (Qk > 0.7; *, Qk > 0.95)
Type I DXR-II vs
DLO1
θ1 = 0.277 ± 0.045 (LRT =
83.233; p = 7.292E-20 )
35, 46, 118, 121, 146, 161*, 176, 198*, 205*, 218, 229, 234, 237, 247*, 265, 282*, 291, 297,
310, 340, 342, 351*, 353*, 376, 404*, 410, 422, 424, 429
DXR-II vs
DLO2
θ1 = 0.253 ± 0.043 (LRT =
114.991; p = 7.907E-27 )
35, 47, 64, 122*, 128, 133, 197*, 202, 205, 210, 239, 248, 250*, 253*, 258*, 260, 282, 291,
296, 305, 310*, 311*, 314, 320, 324*, 330*, 346, 351*, 359, 383*, 410*, 413, 428*, 432
Type II DXR-II vs
DLO1
θ2 = −0.998 ± 0.487
DXR-II vs
DLO2
θ2 = −1.115 ± 0.575
p = posterior probability values; SE Standard Error. LRT and resulting p-values are shown in parentheses. Critical amino acid sites detected as related to functional
divergence with Qk > 70% (*, Qk > 95%) are listed. Seven sites predicted as related to functional divergence of DXR-II from both families DLO1 and DLO2 are
indicated in bold. Numbering refers to Brucella melitensis biovar abortus 2308 DXR-II protein sequence.
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of strains from Rhodopseudomonas palustris (strain
BisB5), a feature perhaps related to the metabolical ver-
satility attributed to this species [31] (Additional file 7).
A similar patchy distribution of DXR-II was observedA
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bution of enzymes of these pathways, revealing the oc-
currence of multiple patterns (Figure 2 and Additional
file 6: Table S3). The majority of surveyed eubacterial ge-
nomes contained genes coding for enzymes of the MEP
pathway, but a significant number of them had lost one
or more of these enzymes. DXR-I would have been pref-
erentially lost among Alphaproteobacterial strains, but
some losses were also found in Firmicutes and Chlo-
roflexi (class A). These species would then exclusively
rely on DXR-II for IPP biosynthesis through the MEP
pathway. A group, mainly composed of Firmicutes
strains showed genes encoding both DXR-II and DXR-I
(class B). A significant number of genomes also encoded
for enzymes of the MVA pathway. Some of these strains
would then use solely the MVA pathway for isoprenoid
biosynthesis, such as the two Chloroflexi representatives
(class C). DXR-II activity has been experimentally shown
from one of these strains, Chloroflexus auranticus J-10-fl,
by complementation assays (Additional file 5). Most of
them also have a complete and functional MEP pathway,
such as Listeria monocytogenes (class D) [6]. Finally,
in the genomes of two Firmicutes strains (Anaerococcus
prevotii DSM 20548 and Finegoldia magna ATCC 29328)
no genes encoding enzymes from the MEP (apart from
DXR-II) or the MVA pathways could be found (class E).
Interestingly however, DXR-II activity had been confirmed
experimentally for the latter [23].
Similarly, the distribution of DXR-II was compared to
that of enzymes of the CP pathway of amino acid bio-
synthesis. The CP represents three enzymatic steps. The
first is the phosporylation of aspartate, carried out by
AK leading to β-aspartyl-phosphate, which in turn is ox-
idized by an ASDH to aspartate semialdehyde. Subse-
quently, HD catalyses the reduction of aspartate beta-
semialdehyde into homoserine, in the third and last step
of the CP pathway (Figure 1). The evolutionary diversifi-
cation of enzymes of the CP in bacteria is known to have
been shaped by gene duplication and fusion events,
resulting in bifunctional AK_HD proteins [33]. Most ge-
nomes of the 51 DXR-II-containing strains encoded AK
and HD. The genomes of five strains also showed bi-
functional AK_HD genes, while the genomes of only
three Alphaproteobacteria strains encoded for ASDH
and were believed to have functional CP (class B)
(Figure 1 and Additional file 6: Table S3). However,
none of the genomes of DXR-II-containing strains enco-
ded the complete set of enzymes of the CP (class A, AK,
HD, AK_HD and ASDH).
We next examined the distribution of biological prop-
erties across DXR-II-containing bacterial strains. For this
purpose, we projected the data contained in the NCBI’s
Microbial Organism Information Page onto the original
set of 1489 bacterial strains, after correcting forambiguities and redundancies. The database, available
for download at ftp://ftp.ncbi.nlm.nih.gov/genomes/
genomeprj_archive/, included categories related to the
ecological requirements of the organism (e.g. habitat,
oxygen requirement, salinity, temperature range, optimal
temperature), morphological features (e.g., shape, ar-
rangement, endospores and motility) and additional
phenotypic traits (e.g., Gram stain, dinucleotide GC con-
tent, genome size and pathogenicity). The distribution of
properties across DXR-II- and non DXR-II-containing
eubacterial strains is shown in Table 3. To test whether
any of these biological properties were differentially rep-
resented in the subset of 51 eubacterial strains
containing DXR-II regarding the remaining non-DXR-II
harbouring strains, we performed Fishers’ exact tests.
According to these tests, none of the categories related
to the ecological requirements of the organism showed a
biased representation among DXR-II-containing strains,
suggesting that these organisms may not live in shared
habitats. A similar unbiased pattern of distribution was
found for additional morphological and phenotypic fea-
tures (Table 3). Only the category “pathogenic in animals”
showed a significant overrepresentation among DXR-II
-containing strains (Table 3). Similarly, for quantitative
properties, such as genome size, GC content and optimal
growth temperature, a Student’s T test was performed to
assess significance of the differences between means.
Again, none of the tests were significant (Table 3).
Comparative sequence-based analysis of HGT in DXR-II
evolution
The markedly discontinuous phylogenetic distribution
shown by DXR-II might be explained by recurrent
events of HGT occurring between unrelated bacterial
strains. So long as the DXR-II sequence retains sequence
features of the donor strain significantly distinct from
that of the genome of the recipient strain, they could be
inferred as being acquired by HGT. Consequently, com-
parative nucleotide sequences analyses of DXR-II against
their host genomes could yield clues about their origin
and the putative role of HGT in the distribution of
DXR-II across eubacteria.
Several methods and criteria were applied to identify
signatures of HGT (please see Methods for a complete
description). Firstly, GC content at the three codon posi-
tions, as well as the total, was estimated. As previously
observed [34,35], GC content was relatively constant
among genes of a particular species’ genomes, although
displaying wide variation among species (Additional file 6:
Table S4). This was particularly evident at the third codon
position, as the majority of these sites are synonymous
and, consequently, differences due to mutational biases
are higher. In contrast, the first and second codon posi-
tions appear to be more conserved between genomes and
Table 3 Distribution of biological properties in DXR-II and
non-DXR-II containing bacterial strains and statistical
tests of enrichment
Biological properties
Number of strains p-value
DXR-II Non-DXR-II
Habitat 41 1166
Host-associated 18 383 0.36
Multiple 16 330 0.33
Specialized 3 148 ND
Terrestrial 2 94 ND
Aquatic 2 211 ND
Oxygen Req 39 1137
Facultative 15 404 0.76
Aerobic 15 413 0.88
Anaerobic 9 284 ND
Salinity 7 245
Non-halophilic 6 171 ND
Moderate halophilic 1 30 ND
Temp. range 38 1202
Mesophilic 36 1013 0.64
Thermophilic 2 107 ND
Optimal temp. a 38.61 (18) 41.21 (555) 0.27
Genome Size a 3.73 (48) 3.59 (1456) 0.50
GC Content a 48.23 (45) 48.63 (1193) 0.84
Shape 43 1239
Rod 29 794 0.90
Coccobacillus 6 21 ND
Coccus 5 188 ND
Filament 2 20 ND
Short rod 1 2 ND
Arrangment 35 899
Singles 17 501 0.77
Pairs 9 209 ND
Chains 4 107 ND
Groups 3 3 ND
Filaments 2 22 ND
Endospores 18 626
Yes 6 121 ND
No 12 505 0.71
Motility 27 947
Yes 22 579 0.37
No 5 365 ND
Gram Stain 39 1050
- 22 704 0.60
+ 17 344 0.35
Table 3 Distribution of biological properties in DXR-II and
non-DXR-II containing bacterial strains and statistical
tests of enrichment (Continued)
Pathogenic in 42 1008
Animal 15 181 0.04
Human 14 264 0.50
No 13 521 0.11
P-values resulting from Fisher’s exact tests are shown for categories
represented in at least 10 bacterial strains. Test significant at p < 0.05 is shown
in bold type. a, for these quantitative properties, the average value (number of
strains is shown between parentheses) and p-values resulting from Student’s T
tests performed to assess significance of the differences between means
are shown.
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Table S4). The GC contents of all DXR-II coding se-
quences were compared to the mean for all genes encoded
by the corresponding genomes. DXR-II from both
Chloroflexi representatives and the single Fusobacteria
representative Sebaldella termitidis ATCC 33386 showed
significantly lower GCt and GC3 content regarding the re-
spective mean for all genes in the genome (Additional file 6:
Table S4). A fourth bacterial strain, Rhizobium NGR234,
showed higher GCt and GC3 content (Additional file 6:
Table S4).
Secondly, we examined for biases in dinucleotide rela-
tive frequencies, a remarkably stable property of the
DNA of an organism claimed to constitute a ‘genomic
signature’ that can discriminate sequences from different
organisms [36]. We focused on the dinucleotide biases
at third and first (3:1) codon positions, which are less
sensitive to selective constrains [37]. Consequently, the
3:1 dinucleotide frequencies were calculated for all DXR-
II coding sequences and for the entire set of genes in the
corresponding genomes. They both showed significant
variation across organisms, and therefore could be used
as such genomic signatures. Significance of the differences
between DXR-II genes and their genomes were examined
by calculating the dinucleotide relative abundance dif-
ference or σ difference (Additional file 6: Table S5) [36].
Pairwise co-variation was further assessed through the
Spearman and Kendall rank tests (Additional file 6: Table
S5). In all but one example, both Spearman’s ρ and
Kendall’s τ correlation coefficients indicated strong
positive correlation. An exception was provided by
Halanaerobium hydrogeniformans, which showed nega-
tive correlation. All tests revealed significant covari-
ation of 3:1 dinucleotide frequencies of DXR-II with the
frequencies of the corresponding genomes, contrary to
the expectations of HGT.
Next, we estimated relative synonymous codon usages
(RSCU) values, which provide with a simple effective
measure of synonymous codon usage bias. Differences in
RSCU between DXR-II genes and all other genes in each
corresponding genome were assessed by means of χ2
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and S. termitidis ATCC 33386 showed the higher χ2 stat-
istic values, revealing higher variation. However, none of
the tests was significant, indicating that DXR-II genes
have a codon usage patterns consistent with that of their
corresponding genomes, and therefore unlikely to reflect
HGT.
Finally, we examined the degree of bias in codon usage
of DXR-II genes towards the codon usage of the most
expressed genes by comparing Codon Adaptation Index
(CAI) values. A significant deviation from the average
CAI of the genome was found in strains of Chloroflexi
and S. termitidis ATCC 33386 (Additional file 6: Table S7).
Discussion and conclusions
The structural and functional diversity of isoprenoids
correlates with the existence of a wide biochemical and
genetic plasticity for their biosynthesis [17]. In eubac-
teria, this is commonly achieved through the use of al-
ternative metabolic pathways and enzymatic steps in
specific lineages. Interesting examples are provided by
HMGR and IDI, which are encoded by at least two dis-
tinct gene families in bacteria. In this paper we focus in
DXR-II, recently characterized as an alternative family to
DXR-I in performing the second step of the MEP path-
way of isoprenoid biosynthesis in a selected group of eu-
bacteria [23].
Apart from the NAD-binding domain with a core
Rossmann-type fold found at the N-terminal region of
all oxidoreductases, no significant similarity at the se-
quence level was observed between DXR-I and DXR-II
to infer homology [23]. Correspondingly, the recent de-
termination of the DXR-II crystal structure showed only
slight structural relationship with DXR-I proteins and
revealed a unique arrangement of the active site [26].
Examples of enzymes catalyzing identical reactions
through the same catalytic mechanisms but showing
structurally unrelated active sites are known outside the
isoprenoid field [38-41]. In some of these though, key
catalytic residues may be conserved between functionally
redundant enzymes, as also reported for DXR-I and
DXR-II [26]. DXR-I and DXR-II likely represent analo-
gous genes that evolved redundant biochemical func-
tions through mechanistic convergence.
Our results support the emergence of the DXR-II fam-
ily through type I, but not type II, functional divergence
from DLO1 and DLO2 families of previously uncharac-
terized oxidoreductases. These data suggest that DXR-II
acquired additional structural and/or functional con-
straints rather than shifted constraints in amino acids
that were already ancestrally constrained. Amino acid
changes critical for functional divergence and acquisition
of DXR-II biochemical activity were predicted, many of
them corresponding to positions highly conserved inDXR-II, but otherwise variable in DLO1 and/or DLO2.
Interestingly, two of these predicted amino acids,
Thr229 and Arg320, had been previously identified for
their role in fosmidomycin/substrate binding and in
dimerization, respectively [26], suggesting that functional
shifts in a limited number of amino acid positions could
be at the origin of the acquisition of DXR-II biochemical
activity.
It could be assumed that the MEP pathway is the an-
cestral route for IPP and isoprenoid biosynthesis in eu-
bacteria, including the membrane-associated hopanoids,
which are among the oldest known biomolecules [42].
The entire set of genes encoding for enzymes involved
in the MEP pathway, including DXR-I, has been found
widespread in all eubacterial taxonomic groups [5]. In a
significant number of DXR-II-containing eubacterial ge-
nomes (31), including those from closely related strains,
DXR-I has been lost. This raises the question of how
DXR-II evolved in DXR-I containing strains, as acquisi-
tion of redundant biochemical activities should not be
favoured by evolution. The DXR-II family could have
emerged under an ecological context that conferred a se-
lective advantage to the emergence and maintenance of
a functionally redundant enzyme, e.g. when gene dosage
is selectively advantageous. Due to the wide and diverse
functions played by isoprenoids and their essential role
for cell viability, critical situations in which their biosyn-
thesis was absolutely required may have occurred mul-
tiple times throughout eubacterial evolution. Emergence
of the DXR-II family should have occurred at an early
time in evolution, as supported by the scattered distribu-
tion of DXR-II and related oxidoreductases from DLO1
and DLO2 families in distantly related lineages of eubac-
teria. After relaxation of that burst in selective con-
straints for isoprenoid biosynthesis, some strains could
then have lost one redundant enzyme, commonly DXR-
II, which shows less catalytic activity in vitro [26]. In
addition, maintenance of DXR-II, which shows less
sensitivity to inhibition by fosmidomycin than DXR-I
[26], might have provided a selective advantage in bac-
terial strains sharing the same ecological niches as those
naturally producing the antibiotic (e.g. Streptomyces
species [43]).
The taxonomic distribution of DXR-II across eubac-
teria showed a marked discontinuity, which was also
verified at the metabolic and phenotypic level. Although
most genes encoding DXR-II were found in eubacteria
with the MEP pathway, their occurrence was not linked
to a unique pattern of distribution of enzymes of the
MEP or MVA pathways. Similarly, HD, the oxidoreduc-
tase family that showed the highest level of similarity
with DXR-II, was found in most DXR-II-containing bac-
terial strains, but not all. In addition, examination of the
distribution of biological properties across DXR-II-containing
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was not linked to a unique pattern of ecological or pheno-
typic traits. The only exception was ‘pathogenic in ani-
mals’, significantly enriched among DXR-II-containing
strains, reflecting the occurrence of DXR-II among patho-
genic strains of Brucella, Bartonella, Listeria and Clostrid-
ium [44-47].
The outstanding phylogenetic discontinuity in DXR-II
distribution across eubacteria could be explained
through two alternative, though not mutually exclusive,
evolutionary mechanisms, i.e., gene gain through HGT
or gene loss. HGT is known to have shaped the evolu-
tion of multiple metabolic pathways, including IPP and
isoprenoid biosynthesis [8,24,48]. However, a unique
event of HGT cannot properly explain DXR-II phyl-
ogeny. According to our phylogenetic analysis, such
HGT events should instead have occurred at different
time points throughout eubacterial evolution, e.g. be-
tween the Alphaproteobacteria and Firmicutes phyla, be-
tween the Alphaproteobacteria and Betaproteobacteria
classes within the proteobacteria phylum, between
Firmicutes and specific Chloroflexi strains or between
Firmicutes and specific Fusobacteria. More recently,
HGT should also have occurred between closely related
Alphaproteobacteria or Firmicute strains. If this was the
case, HGT events should have left a signature of atypical
sequence features in DXR-II genes, provided they were
recent enough and occurring between distantly taxo-
nomically related donor and acceptor bacterial strains
[34,35]. Weak signatures of HGT were found only in
Chloroflexi and the Fusobacterium S. termitidis ATCC
33386 at the level of GC content and CAI values. How-
ever, no biases in dinucleotide frequencies or codon
usage were observed in any strain comparison. These re-
sults suggested that HGT events were not at the origin
of all discontinuities, or were so ancient that DXR-II
genes ameliorated their sequence to specific base com-
position and codon usage of the host genome, making
them indistinguishable from ancestral sequences [34,35].
Consequently, although old episodic events of HGT
cannot be excluded, the alternative hypothesis of recur-
rent DXR-II (or eventually DXR-I) gene loss is more
likely to explain DXR-II phylogeny. This mechanism has
been traditionally considered less parsimonious, as it in-
volves a complex ancestor and gene loss events occur-
ring independently at multiple evolutionary lineages.
However, recent works suggests that, on average, gene
loss might be a more likely event than gene gain through
HGT [49-51].
The DXR-I/DXR-II model constitutes an exceptional
natural model to experimentally test the emergence and
maintenance of redundant gene function between non-
homologous genes as a result of convergent evolution, as
opposed to their emergence from intragenomic duplicates,or paralogs. Furthermore, our results highlight the import-
ance of the functional characterization of evolutionary
shortcuts in isoprenoid biosynthesis for screening specific
antibacterial drugs and for regulating the production of
isoprenoids of human interest.
Methods
Sequence and phylogenetic analysis
Sequence databases from the whole sequenced genomes
of 1489 bacterial strains were downloaded from the NCBI.
Orthologs of enzymes from the MEP and MVA pathways
for IPP biosynthesis, as well as for enzymes of the CP of
amino acid biosynthesis (Figure 1), were defined as the
best reciprocal hits resulting from all-against-all local
BLASTP-searches with an E-value cutoff of 1E-5 and a bit
score cutoff of 50 [52] using selected previously character-
ized sequences as queries (Additional file 6: Table S2).
Only hits corresponding to full-length sequences were
considered. Resulting hits were scanned for the presence
of INTERPRO domains.
Phylogenetic analysis was performed on the basis of an
alignment of protein sequences obtained using MUSCLE
[53]. Maximum Likelihood (ML) phylogenetic recon-
struction was carried out in PhyML v3.0 [54] using the
LG protein evolution model [55] and heterogeneity of
amino acid substitution rates corrected using a γ-
distribution (G) with eight categories plus a proportion
of invariant sites (I), selected by ProtTest v2.4 as the
best-fitting amino acid substitution model according to
the Akaike information criterion [56]. Starting phylogen-
etic trees were constructed using the modified program
BIONJ. Tree topology searching was optimized using the
subtree pruning and regrafting option. The statistical
support of the retrieved topology was assessed using the
Shimodaira-Hasegawa-like approximate likelihood ratio
test (aLRT) [57].
Bayesian analysis was conducted in MrBayes v3.1.2
[58] using the WAG model [59] plus G with eight cat-
egories plus I. Searches were run using four Markov
(MCMC) chains of length 1000000 generations sampling
every 100th tree. Once stationary phase was reached
(determined by the average standard deviation of split
sequences approaching 0, which reflects convergence of
independent tree samples), the first 2500 trees were
discarded as burn-in, and a 50% majority-rule consensus
tree was then constructed to evaluate Bayesian posterior
probabilities on clades. Neighbor Joining phylogenetic
analysis was performed in MEGA 5.0 [60]. The evolu-
tionary distances for Neighbor Joining phylogenetic re-
construction were computed using the Poisson
correction method. To obtain statistical support on the
resulting clades, a bootstrap analysis with 1000 replicates
was performed. Resulting trees were represented and
edited using FigTree v1.3.1.
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The analysis of functional divergence was performed using
DIVERGE v2.0 [61]. DIVERGE performs the ML estima-
tion of the theta (θ) type-I and type-II coefficients of func-
tional divergence, based on the occurrence of altered
selective constraints or radical shifts of physicochemical
properties, respectively [27,28]. θ value indicates the ex-
tent of functional divergence, ranging from 0, no func-
tional divergence to 1, representing maximum divergence.
Functional divergence can be explicitly tested by compar-
ing the fit of a model allowing for functional divergence
versus a null model in which functional divergence is not
permitted (θ = 0). A Likelihood Ratio Test (LRT) is then
used to examine the significance of differences between
the lnL values of the two nested models (calculated as
2ΔLnL -twice the difference between their lnL values)
[62]. As the LRT asymptotically follows a χ2 distribution
with a number of degrees of freedom equal to one, i.e. the
differences in number of parameters between the models
being compared (θ), a p-value for the fitting of the model
accounting for functional divergence can be computed.
DIVERGE also uses a site-specific profile to estimate the
posterior probabilities (Qk) of individual amino acid sites
to be critical for functional divergence.
G + C% content, dinucleotide frequencies, codon usage,
and CAI analyses
The following sequence features i) GC% content at three
codon positions and total (GC1, GC2, GC3 and GCt), ii)
dinucleotide frequencies at 3:1 codon sites (third base
and first base of the succeeding codon) and iii) the rela-
tive synonymous codon usages (RSCU) were extracted
for individual DXR-II sequences and the rest of genes in
the corresponding genomes through PERL and R scripts
using cpan and bioperl modules. Codon Adaptation In-
dexes (CAI) [63] for individual genes and genomes were
calculated using the method depicted in [64] as imple-
mented in DAMBE software [65]. Comparative analyses of
these sequence features between DXR-II genes and the
rest of genes in the genome were performed and differ-
ences assessed using different statistical tests.
i) Differences in G and C nucleotides content were
considered as significant when GC% deviated by two or
more standard errors (SEs) regarding the respective
means for all genes in the genome or deviations at first
and third codon position were of the same sign and at
least one was higher two or more SEs [35,66].
ii) Dinucleotide relative frequencies were calculated as:
ρXY ¼
f XY
f X f Y
Where fX denotes the frequency of the mononucleo-
tide X and fXY the frequency of the dinucleotide XY. Thearray of ρXY dinucleotide values define the genomic sig-
nature of a given species’ genome [36]. A simple way to
compute differences in dinucleotide relative frequencies
between a given gene (f ) and the value of the entire gen-
ome (g) is through the absolute difference (σ difference)
calculated as:
σ f ; gð Þ ¼ 1
16
∑
XY
ρXY að Þ−ρXY bð Þ
 
averaged over all 16 dinucleotides [67]. Furthermore,
pairwise covariation of the 3:1 dinucleotide differences
were assessed using the Spearman’s rank correlation co-
efficient ρ [68] and the Kendall’s rank correlation coeffi-
cient τ [69]. Both are nonparametric statistics allowing
testing for dependence between two variables.
iii) RSCU provides with a simple effective measure of
synonymous codon usage bias, in which codon frequen-
cies are normalized by the frequency expected under the
assumption of equal usage of synonymous codons for a
given amino acid [70].
RSCUi ¼ Xi
1
n
Xn
i¼1
Xi
For synonymous codon i of an n-fold degenerate amino
acid, where X is the number of occurrences of codon i,
and n the number of synonymous codons encoding for a
given amino acid i.e. 1, 2, 3, 4, or 6. In the absence of any
codon usage bias (i.e. all synonymous codons are used
equally), the RSCU value would be 1. A codon that is used
less or more frequently than expected will have an RSCU
value < or > than 1, respectively. Start, stop and tryptophan
codons were excluded from the analysis. To measure bias
in synonymous codon usage between DXR-II and all genes
in the genome, a χ2 test of RSCU with 41 degrees of free-
dom was implemented [34].
iv) CAI was used as an alternative method to deter-
mine the degree of bias in the synonymous codon usage
of the DXR-II gene regarding the optimal codon usage in
the genome [34,63]. RSCU was firstly determined for all
genes in each species genome, and subsequently used as
reference set for the frequencies of the optimal codons
in each species [65]. CAI is calculated as
CAI ¼ CAIobs
CAI max
where CAIobs is the mean of the RSCUs for all codons
in a particular gene, and CAImax is the mean of the
RSCU for the most frequently used codons for an amino
acid in a genome. CAI ranges from 0 to 1, being 1 if the
gene only uses the most frequently used synonymous co-
dons in the reference set. Differences in CAI between
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Availability of supporting data
The multiple sequence alignment and the phylogenetic
tree-files supporting the results of this article have been
deposited and are publicly available in the TreeBASE
repository under accession numbers: S14611 (http://purl.
org/phylo/treebase/phylows/study/TB2:S14611).
Additional files
Additional file 1: Multiple alignment of 130 DRL and DLO related
protein sequences. Positions conserved in 100%, 70% or 40% of the
sequences are shown in black, dark grey and light grey, respectively.
Strain names are grouped as DXR-II, DLO1 (grey shadow) and DLO2.
Additional file 2: ML phylogeny of DXR-II and DLO related
sequences. ML cladogram depicting the evolutionary relationships
among 53 DXR-II and 77 related protein sequences. Statistical support for
clades (ML aLRT support values) is indicated next to nodes.
Additional file 3: Bayesian phylogeny of DXR-II and DLO related
sequences. Bayesian cladogram depicting the evolutionary relationships
among 53 DXR-II and 77 related protein sequences. Statistical support for
clades (posterior probabilities) is indicated next to nodes.
Additional file 4: Neighbor Joining phylogeny of DXR-II and DLO
related sequences. Neighbor Joining cladogram depicting the
evolutionary relationships among 53 DXR-II and 77 related protein
sequences. Statistical support for clades (bootstrap values) is indicated
next to nodes.
Additional file 5: Complementation of DXR-deficient E. coli cells
with putative DXR-II sequences from Chloroflexus auranticus J-10-fl.
The putative DXR-II sequences were PCR-amplified from genomic DNA
and cloned into pJET1.2. The corresponding constructs and positive and
negative controls (C-, empty vector; C+, DXR-II (YP_418479.1) from B.
melitensis biovar abortus 2308) were used to transform EcAB4-10 cells
[23]. Ability of the cloned gene to rescue growth of this DXR-deficient
mutant strain was ascertained by monitoring growth on plates either
supplemented (+) or not (−) with 1 mM MVA as indicated. 1)
YP_001634831.1, 2) YP_001634944.1, and 3) YP_001636771.1.
Additional file 6: Table S1. List of amino acid sites detected as related
to functional divergence of DXR-II vs DLO1 and DXR-II vs DLO2.
Table S2. List of sequences used as queries in BLAST searches for
enzymes of the MEP, MVA and CP pathway, and the corresponding
bacterial strain. Table S3. Distribution of enzymes of the MEP, MVA and
the CP pathways across 128 whole sequenced bacterial strains. Table S4.
GC content of DXR-II genes and corresponding genomes. Table S5. 3:1
relative dinucleotide frequencies at DXR-II genes and their corresponding
genomes and statistical tests of co-variation. Table S6. RSCU values at
DXR-II genes and their corresponding genomes and statistical tests of
independence. Table S7. CAI values for DXR-II genes and the average for
all genes in the corresponding genomes.
Additional file 7: Distribution of DXR-I and DXR-II in
Alphaproteobacteria. The occurrence of DXR-I and DXR-II is represented
for alphaproteobacterial strains with full sequenced genomes in a
phylogenetic context, according to the robust species tree reported in [30].
Additional file 8: Distribution of DXR-I and DXR-II in Firmicutes. The
occurrence of DXR-I and DXR-II is represented for strains with full
sequenced genomes in a phylogenetic context, according to the robust
species tree for Firmicutes reported in [32].
Abbreviations
AK: Aspartokinase; ASDH: Aspartate semialdehyde dehydrogenase;
CAI: Codon adaptation index; CP: Common pathway; HGT: Horizontal gene
transfer; DLO: DXR-II-Like oxidoreductases; DXR: DeoxyXylulose 5-phosphatereductoisomerase; DMAPP: DiMethylAllyl diphosphate; DXR like: DXR-II;
HD: Homoserine dehydrogenase; HMGR: Hydroxy-3-Methyl-Glutaryl-CoA
Reductase; IDI: IPP isomerase; IPP: Isopentenyl diphosphate; LRT: Likelihood
ratio test; MEP: methylerythritol 4-phosphate; MVA: Mevalonate;
ML: Maximum likelihood; RSCU: Relative synonymous codon usage;
UID: (taxonomy) Unique Identifier.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LCP and AL collected data. LCP, AL and JPG analysed data. LCP, AL, JPG, FJS,
VAA and MRC contributed to the interpretation of the data. LCP and MRC
conceived the study and participated in its design. LCP wrote the
manuscript with significant contributions by JPG, FJS, VA and MRC. All
authors have read and approved the final manuscript.
Acknowledgements
We thank all our laboratory members for stimulating discussions and
suggestions. We thank Derek Taylor and Mario A Fares for critical reading of
the manuscript and helpful comments. Financial support for this research
was provided by the Spanish Ministerio de Ciencia e Innovación (grants
BIO2011-23680 to MRC and BFU2011-25658 to FJS) and Generalitat de
Catalunya (2009SGR-26 and XRB) to MRC.
Author details
1Institute for Plant Molecular and Cell Biology - IBMCP (CSIC-UPV), Integrative
Systems Biology Group, C/ Ingeniero Fausto Elio s/n., Valencia 46022, Spain.
2Department of Biological Sciences, SUNY-University at Buffalo, North
Campus. 109 Cooke Hall, Buffalo, NY 14260, USA. 3Centre for Research in
Agricultural Genomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra,
Barcelona 08193, Spain. 4Department of Molecular Biology, Universidad de
Cantabria and Instituto de Biomedicina y Biotecnología de Cantabria
(IBBTEC), UC-CSIC-SODERCAN, Avda. de los Castros s/n, Santander
E-39005Cantabria, Spain.
Received: 14 May 2013 Accepted: 16 August 2013
Published: 3 September 2013
References
1. Croteau R, Kutchan TM, Lewis NG: Secondary Metabolites. In Biochemistry &
Molecular Biology of Plants. Edited by Buchanan WG B, Jones R, American
Society of Plant Physiologists; 2000:1250–1318.
2. Daum M, Herrmann S, Wilkinson B, Bechthold A: Genes and enzymes
involved in bacterial isoprenoid biosynthesis. Curr Opin Chem Biol 2009,
13(2):180–188.
3. Kuzuyama T, Seto H: Diversity of the biosynthesis of the isoprene units.
Nat Prod Rep 2003, 20(2):171–183.
4. Rodríguez-Concepción M, Boronat A: Elucidation of the methylerythritol
phosphate pathway for isoprenoid biosynthesis in bacteria and plastids.
A metabolic milestone achieved through genomics. Plant Physiol 2002,
130:1079–1089.
5. Lange BM, Rujan T, Martin W, Croteau R: Isoprenoid biosynthesis: the
evolution of two ancient and distinct pathways across genomes.
Proc Natl Acad Sci U S A 2000, 97(24):13172–13177.
6. Begley M, Gahan CG, Kollas AK, Hintz M, Hill C, Jomaa H, Eberl M: The
interplay between classical and alternative isoprenoid biosynthesis
controls gammadelta T cell bioactivity of Listeria monocytogenes.
FEBS Lett 2004, 561(1–3):99–104.
7. Laupitz R, Hecht S, Amslinger S, Zepeck F, Kaiser J, Richter G, Schramek N,
Steinbacher S, Huber R, Arigoni D, et al: Biochemical characterization of
Bacillus subtilis type II isopentenyl diphosphate isomerase, and
phylogenetic distribution of isoprenoid biosynthesis pathways. Eur J
Biochem 2004, 271(13):2658–2669.
8. Boucher Y, Doolittle WF: The role of lateral gene transfer in the evolution
of isoprenoid biosynthesis pathways. Mol Microbiol 2000, 37:703–716.
9. Phillips MA, Leon P, Boronat A, Rodriguez-Concepcion M: The plastidial
MEP pathway: unified nomenclature and resources. Trends Plant Sci 2008,
13(12):619–623.
10. Jomaa H, Wiesner J, Sanderbrand S, Altincicek B, Weidemeyer C, Hintz M,
Turbachova I, Eberl M, Zeidler J, Lichtenthaler HK, et al: Inhibitors of the
Carretero-Paulet et al. BMC Evolutionary Biology 2013, 13:180 Page 17 of 18
http://www.biomedcentral.com/1471-2148/13/180nonmevalonate pathway of isoprenoid biosynthesis as antimalarial
drugs. Science 1999, 285(5433):1573–1576.
11. Kuzuyama T, Seto H: Two distinct pathways for essential metabolic
precursors for isoprenoid biosynthesis. Proc Jpn Acad Ser B Phys Biol Sci
2012, 88(3):41–52.
12. Lichtenthaler HK: The 1-Deoxy-D-Xylulose-5-Phosphate pathway of
Isoprenoid Biosynthesis in plants. Annu Rev Plant Physiol Plant Mol Biol
1999, 50:47–65.
13. Rodríguez-Concepción M, Boronat A: Isoprenoid biosynthesis in
prokaryotic organisms. In Isoprenoid Synthesis in Plants and Microorganisms.
Edited by Bach TJ, Rohmer M. New York: Springer; 2013:1–16.
14. Rodriguez-Concepcion M: The MEP pathway: a new target for the
development of herbicides, antibiotics and antimalarial drugs. Curr
Pharm Des 2004, 10(19):2391–2400.
15. Rohdich F, Bacher A, Eisenreich W: Isoprenoid biosynthetic pathways as
anti-infective drug targets. Biochem Soc Trans 2005, 33(Pt 4):785–791.
16. Bouvier F, Rahier A, Camara B: Biogenesis, molecular regulation and
function of plant isoprenoids. Prog Lipid Res 2005, 44(6):357–429.
17. Perez-Gil J, Rodriguez-Concepcion M: Metabolic plasticity for isoprenoid
biosynthesis in bacteria. Biochem J 2013, 452(1):19–25.
18. Boucher Y, Huber H, L’Haridon S, Stetter KO, Doolittle WF: Bacterial origin
for the isoprenoid biosynthesis enzyme HMG-CoA reductase of the
archaeal orders thermoplasmatales and archaeoglobales. Mol Biol Evol
2001, 18(7):1378–1388.
19. Gophna U, Thompson JR, Boucher Y, Doolittle WF: Complex histories of
genes encoding 3-hydroxy-3-methylglutaryl-CoenzymeA reductase.
Mol Biol Evol 2006, 23(1):168–178.
20. Kaneda K, Kuzuyama T, Takagi M, Hayakawa Y, Seto H: An unusual
isopentenyl diphosphate isomerase found in the mevalonate pathway
gene cluster from Streptomyces sp. strain CL190. Proc Natl Acad Sci USA
2001, 98(3):932–937.
21. Barkley SJ, Cornish RM, Poulter CD: Identification of an Archaeal type II
isopentenyl diphosphate isomerase in methanothermobacter
thermautotrophicus. J Bacteriol 2004, 186(6):1811–1817.
22. Barkley SJ, Desai SB, Poulter CD: Type II isopentenyl diphosphate
isomerase from synechocystis sp. strain PCC 6803. J Bacteriol 2004,
186(23):8156–8158.
23. Sangari FJ, Perez-Gil J, Carretero-Paulet L, Garcia-Lobo JM, Rodriguez-Concepcion
M: A new family of enzymes catalyzing the first committed step of the
methylerythritol 4-phosphate (MEP) pathway for isoprenoid biosynthesis in
bacteria. Proc Natl Acad Sci U S A 2010, 107(32):14081–14086.
24. Boucher Y, Douady CJ, Papke RT, Walsh DA, Boudreau MER, Nesbø CL, Case
RJ, Doolittle WF: Lateral gene transfer and the origins of prokaryotic
groups. Annu Rev Genet 2003, 37:283–328.
25. Moreno-Hagelsieb G, Latimer K: Choosing BLAST options for better
detection of orthologs as reciprocal best hits. Bioinformatics 2008,
24(3):319–324.
26. Perez-Gil J, Calisto BM, Behrendt C, Kurz T, Fita I, Rodriguez-Concepcion M:
Crystal structure of brucella abortus deoxyxylulose-5-phosphate
reductoisomerase-like (DRL) enzyme involved in isoprenoid biosynthesis.
J Biol Chem 2012, 287(19):15803–15809.
27. Gu X: Statistical methods for testing functional divergence after gene
duplication. Mol Biol Evol 1999, 16(12):1664–1674.
28. Gu X: A simple statistical method for estimating type-II (cluster-specific)
functional divergence of protein sequences. Mol Biol Evol 2006,
23(10):1937–1945.
29. Humphrey W, Dalke A, Schulten K: VMD: visual molecular dynamics. J Mol
Graph 1996, 14(1):33–38. 27–38.
30. Williams KP, Sobral BW, Dickerman AW: A robust species tree for the
alphaproteobacteria. J Bacteriol 2007, 189(13):4578–4586.
31. Larimer FW, Chain P, Hauser L, Lamerdin J, Malfatti S, Do L, Land ML,
Pelletier DA, Beatty JT, Lang AS, et al: Complete genome sequence of the
metabolically versatile photosynthetic bacterium rhodopseudomonas
palustris. Nat Biotechnol 2004, 22(1):55–61.
32. Moreno-Letelier A, Olmedo G, Eguiarte LE, Martinez-Castilla L, Souza V:
Parallel evolution and horizontal gene transfer of the pst operon in
firmicutes from oligotrophic environments. Int J Evol Biol 2011,
2011:781642.
33. Fondi M, Brilli M, Fani R: On the origin and evolution of biosynthetic
pathways: integrating microarray data with structure and organization of
the common pathway genes. BMC bioinformatics 2007, 8(Suppl 1):S12.34. Lawrence JG, Ochman H: Amelioration of bacterial genomes: rates of
change and exchange. J Mol Evol 1997, 44(4):383–397.
35. Lawrence JG, Ochman H: Molecular archaeology of the Escherichia coli
genome. Proc Natl Acad Sci U S A 1998, 95(16):9413–9417.
36. Karlin S, Burge C: Dinucleotide relative abundance extremes: a genomic
signature. Trends Genet 1995, 11(7):283–290.
37. Hooper SD, Berg OG: Detection of genes with atypical nucleotide
sequence in microbial genomes. J Mol Evol 2002, 54(3):365–375.
38. Genschel U: Coenzyme a biosynthesis: reconstruction of the pathway in
archaea and an evolutionary scenario based on comparative genomics.
Mol Biol Evol 2004, 21(7):1242–1251.
39. Gherardini PF, Wass MN, Helmer-Citterich M, Sternberg MJ: Convergent
evolution of enzyme active sites is not a rare phenomenon. J Mol Biol
2007, 372(3):817–845.
40. Kulkarni N, Lakshmikumaran M, Rao M: Xylanase II from an alkaliphilic
thermophilic Bacillus with a distinctly different structure from other
xylanases: evolutionary relationship to alkaliphilic xylanases. Biochem
Biophys Res Commun 1999, 263(3):640–645.
41. Watanabe S, Yamada M, Ohtsu I, Makino K: alpha-ketoglutaric
semialdehyde dehydrogenase isozymes involved in metabolic pathways
of D-glucarate, D-galactarate, and hydroxy-L-proline. Molecular and
metabolic convergent evolution. J Biol Chem 2007, 282(9):6685–6695.
42. Brocks JJ, Logan GA, Buick R, Summons RE: Archean molecular fossils and
the early rise of eukaryotes. Science 1999, 285(5430):1033–1036.
43. Iguchi E, Okuhara M, Kohsaka M, Aoki H, Imanaka H: Studies on new
phosphonic acid antibiotics. II. Taxonomic studies on producing
organisms of the phosphonic acid and related compounds. J Antibiot
(Tokyo) 1980, 33(1):19–23.
44. Guptill L: Bartonellosis. Vet Microbiol 2010, 140(3–4):347–359.
45. Allerberger F, Wagner M: Listeriosis: a resurgent foodborne infection.
Clin Microbiol Infect 2010, 16(1):16–23.
46. von Bargen K, Gorvel JP, Salcedo SP: Internal affairs: investigating the
brucella intracellular lifestyle. FEMS Microbiol Rev 2012, 36(3):533–562.
47. Wells CL, Wilkins TD: Clostridia: sporeforming anaerobic bacilli. In Medical
Microbiology. 4th edition. Edited by Baron S. Galveston (TX); 1996.
48. Ochman H, Lawrence JG, Groisman EA: Lateral gene transfer and the
nature of bacterial innovation. Nature 2000, 405(6784):299–304.
49. Kunin V, Ouzounis CA: The balance of driving forces during genome
evolution in prokaryotes. Genome Res 2003, 13(7):1589–1594.
50. Kurland CG, Canback B, Berg OG: Horizontal gene transfer: a critical view.
Proc Natl Acad Sci U S A 2003, 100(17):9658–9662.
51. Mirkin BG, Fenner TI, Galperin MY, Koonin EV: Algorithms for computing
parsimonious evolutionary scenarios for genome evolution, the last
universal common ancestor and dominance of horizontal gene transfer
in the evolution of prokaryotes. BMC Evol Biol 2003, 3:2.
52. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ:
Gapped BLAST and PSI-BLAST: a new generation of protein database
search programs. Nucleic Acids Res 1997, 25(17):3389–3402.
53. Edgar RC: MUSCLE: multiple sequence alignment with high accuracy and
high throughput. Nucleic Acids Res 2004, 32(5):1792–1797.
54. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O: New
algorithms and methods to estimate maximum-likelihood phylogenies:
assessing the performance of PhyML 3.0. Syst Biol 2010, 59(3):307–321.
55. Le SQ, Gascuel O: An improved general amino acid replacement matrix.
Mol Biol Evol 2008, 25(7):1307–1320.
56. Abascal F, Zardoya R, Posada D: ProtTest: selection of best-fit models of
protein evolution. Bioinformatics 2005, 21(9):2104–2105.
57. Anisimova M, Gascuel O: Approximate likelihood-ratio test for branches: a
fast, accurate, and powerful alternative. Syst Biol 2006, 55(4):539–552.
58. Ronquist F, Huelsenbeck JP: MrBayes 3: Bayesian phylogenetic inference
under mixed models. Bioinformatics 2003, 19(12):1572–1574.
59. Whelan S, Goldman N: A general empirical model of protein evolution
derived from multiple protein families using a maximum-likelihood
approach. Mol Biol Evol 2001, 18(5):691–699.
60. Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary
Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol 2007,
24(8):1596–1599.
61. Gu X, Vander Velden K: DIVERGE: phylogeny-based analysis for functional-
structural divergence of a protein family. Bioinformatics 2002, 18(3):500–501.
62. Goldman N, Yang Z: A codon-based model of nucleotide substitution for
protein-coding DNA sequences. Mol Biol Evol 1994, 11(5):725–736.
Carretero-Paulet et al. BMC Evolutionary Biology 2013, 13:180 Page 18 of 18
http://www.biomedcentral.com/1471-2148/13/18063. Sharp PM, Li WH: The codon Adaptation Index–a measure of directional
synonymous codon usage bias, and its potential applications.
Nucleic Acids Res 1987, 15(3):1281–1295.
64. Xia X: An improved implementation of codon adaptation index.
Evol Bioinform Online 2007, 3:53–58.
65. Xia X, Xie Z: DAMBE: software package for data analysis in molecular
biology and evolution. J Hered 2001, 92(4):371–373.
66. Garcia-Vallve S, Romeu A, Palau J: Horizontal gene transfer in bacterial and
archaeal complete genomes. Genome Res 2000, 10(11):1719–1725.
67. Karlin S: Detecting anomalous gene clusters and pathogenicity islands in
diverse bacterial genomes. Trends Microbiol 2001, 9(7):335–343.
68. Spearman C: The proof and measurement of association between Two
things. Am J Psychol 1904, 15(1):72–101.
69. Kendall MG: A new measure of rank correlation. Biometrika 1938,
30(1–2):81–93.
70. Sharp PM, Tuohy TM, Mosurski KR: Codon usage in yeast: cluster analysis
clearly differentiates highly and lowly expressed genes. Nucleic Acids Res
1986, 14(13):5125–5143.
doi:10.1186/1471-2148-13-180
Cite this article as: Carretero-Paulet et al.: Evolutionary diversification
and characterization of the eubacterial gene family encoding DXR type
II, an alternative isoprenoid biosynthetic enzyme. BMC Evolutionary
Biology 2013 13:180.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
